Application form: tablets, capsules
Indication group: otorhinolaryngologicals
Active substance: Benzoxonii chloridum 1 mg, Lidocaini hydrochloridum monohydricum 1 mg
minimum amount for dispatch: Orofar contains a substance effective against infection and a substance which causes desensitisation (anaesthetic). It is used for the treatment of inflammations of the oral cavity and the pharynx. Orofar is available in form of lozenges, spray and solution for rinsing or gargling.
Recommended dosage: Slowly dissolve 1 lozenge in your mouth every 2-3 hours. Dosage is possible increase to 1 or two lozenge every hour. Do not exceed a dose of 10 lozenges a day. Pastilles should not be chewed or swallowed.
Manufacturer: GlaxoSmithKline Consumer Healthcare GmbH & Co. KG, Germany
|SUKL název||OROFAR 1MG/1MG PAS 24|